Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)

China flag China · Delayed Price · Currency is CNY
13.21
+0.06 (0.46%)
Apr 29, 2026, 3:04 PM CST
-13.09%
Market Cap 7.18B
Revenue (ttm) 1.19B
Net Income (ttm) 258.62M
Shares Out 543.69M
EPS (ttm) 0.43
PE Ratio 30.82
Forward PE 16.51
Dividend 0.11 (0.86%)
Ex-Dividend Date Apr 30, 2025
Volume 7,446,326
Average Volume 11,633,221
Open 13.28
Previous Close 13.15
Day's Range 13.06 - 13.28
52-Week Range 12.99 - 19.67
Beta 0.60
RSI 36.47
Earnings Date Apr 18, 2026

About SHE:300401

Zhejiang Garden Biopharmaceutical Co.,Ltd. engages in the research, development, production and sales of vitamin products and pharmaceuticals in China. The company offers lanolin cholesterol series products, such as cholesterol and feed grade cholesterol; vitamin D3 products, including food additives compound nutrient fortifier SDS, food additives compound nutritional fortifier CO and MO, cholecalciferol, vitamin D3 particles, feed additive vitamin D3 oil, and VD3 resin oil; and 25 HydroxyVitamin D3 Progen, 25 hydroxyvitamin D3, and 25 hydroxyv... [Read more]

Sector Healthcare
Founded 2000
Employees 1,021
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300401
Full Company Profile

Financial Performance

In 2025, SHE:300401's revenue was 1.24 billion, a decrease of -0.47% compared to the previous year's 1.24 billion. Earnings were 304.86 million, a decrease of -1.41%.

Financial Statements

News

There is no news available yet.